cTRL is a California-based biotechnology company that researches and develops next-generation cell therapies for the treatment of solid tumors... Read more
CTRL Therapeutics CEO: Derrell D. Porter

CEO

Derrell D. Porter

CEO Approval Rating

- -/100

2020

Add Location

PrivateIndependent Company

Est. Annual Revenue
<$1M
Agree?
Est. Employees
<10
Agree?
Funding
$26.6M

Trending Companies